triamcinolone acetonide has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Mugheisib, M; Benecke, R; Hoffmann, F; Kamin, F; Koehler, W; Rommer, PS; Winkelmann, A; Zettl, UK | 1 |
| Brune, N; Hellwig, K; Lukas, C; Müller, T; Przuntek, H; Schimrigk, S | 1 |
1 trial(s) available for triamcinolone acetonide and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.
Topics: Combined Modality Therapy; Disability Evaluation; Female; Glucocorticoids; Humans; Injections, Spinal; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Muscle Spasticity; Quality of Life; Treatment Outcome; Triamcinolone Acetonide; Walking | 2015 |
1 other study(ies) available for triamcinolone acetonide and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Repeat intrathecal triamcinolone acetonide application reduces acute occurring painful dysesthesia in patients with relapsing remitting multiple sclerosis.
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Immunosuppressive Agents; Injections, Spinal; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting; Pain; Spinal Cord; Triamcinolone Acetonide | 2006 |